Hemopexin reverses activation of lung eIF2α and decreases mitochondrial injury in chlorine-exposed mice

We assessed the mechanisms by which nonencapsulated heme, released in the plasma of mice after exposure to chlorine (Cl2) gas, resulted in the initiation and propagation of acute lung injury. We exposed adult male and female C57BL/6 mice to Cl2 (500 ppm for 30 min), returned them to room air, and injected them intramuscularly with either human hemopexin (hHPX; 5 µg/g BW in 50-µL saline) or vehicle at 1 h post-exposure. Upon return to room air, Cl2-exposed mice, injected with vehicle, developed respiratory acidosis, increased concentrations of plasma proteins in the alveolar space, lung mitochondrial DNA injury, increased levels of free plasma heme, and major alterations of their lung proteome. hHPX injection mice mitigated the onset and development of lung and mitochondrial injury and the increase of plasma heme, reversed the Cl2-induced changes in 83 of 237 proteins in the lung proteome at 24 h post-exposure, and improved survival at 15 days post-exposure. Systems biology analysis of the lung global proteomics data showed that hHPX reversed changes in a number of key pathways including elF2 signaling, verified by Western blotting measurements. Recombinant human hemopexin, generated in tobacco plants, injected at 1 h post-Cl2 exposure, was equally effective in reversing acute lung and mtDNA injury. The results of this study offer new insights as to the mechanisms by which exposure to Cl2 results in acute lung injury and the therapeutic effects of hemopexin.NEW & NOTEWORTHY Herein, we demonstrate that exposure of mice to chlorine gas causes significant changes in the lung proteome 24 h post-exposure. Systems biology analysis of the proteomic data is consistent with damage to mitochondria and activation of eIF2, the master regulator of transcription and protein translation. Post-exposure injection of hemopexin, which scavenges free heme, attenuated mtDNA injury, eIF2α phosphorylation, decreased lung injury, and increased survival.

Errataetall:

UpdateOf: bioRxiv. 2023 Aug 19;:. - PMID 37645744

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:326

Enthalten in:

American journal of physiology. Lung cellular and molecular physiology - 326(2024), 4 vom: 01. März, Seite L440-L457

Sprache:

Englisch

Beteiligte Personen:

Matalon, Sadis [VerfasserIn]
Yu, Zhihong [VerfasserIn]
Dubey, Shubham [VerfasserIn]
Ahmad, Israr [VerfasserIn]
Stephens, Emily M [VerfasserIn]
Alishlash, Ammar Saadoon [VerfasserIn]
Meyers, Ashley [VerfasserIn]
Cossar, Douglas [VerfasserIn]
Stewart, Donald [VerfasserIn]
Acosta, Edward P [VerfasserIn]
Kojima, Kyoko [VerfasserIn]
Jilling, Tamas [VerfasserIn]
Mobley, James A [VerfasserIn]

Links:

Volltext

Themen:

42VZT0U6YR
4R7X1O2820
9013-71-2
Chlorine
DNA, Mitochondrial
Heme
Hemopexin
Journal Article
Lung injury
Mitochondrial DNA
Proteome
Proteomics
Recombinant hemopexin

Anmerkungen:

Date Completed 28.03.2024

Date Revised 28.03.2024

published: Print-Electronic

UpdateOf: bioRxiv. 2023 Aug 19;:. - PMID 37645744

Citation Status MEDLINE

doi:

10.1152/ajplung.00273.2023

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366411985